Meanwhile, a study found that nonalcoholic fatty liver disease patients exhibited increased SIRT4 expression and potentially a decrease in fatty acid oxidation in the liver (Wu et al., 2014). This evidence concerns the gene SIRT4 and metabolic dysfunction-associated steatotic liver disease.